FDA Answers 2Firsts On Site: Supports Innovative E-Cigarettes Entering the U.S. Market to Help Smoki

  On the afternoon of September 21, at the GTNF forum, FDA Center for Tobacco Products Director Brian A. King responded to two questions from 2Firsts regarding the e-cigarette category.

[2Firsts reporting from Seoul, South Korea] On the afternoon of September 21, after the conclusion of the GTNF forum themed "Protecting Youth Use Is Everyone's Responsibility," 2Firsts asked Brian A. King, Director of the Center for Tobacco Products at the U.S. Food and Drug Administration (FDA): Today, innovation in harm reduction products is developing rapidly, with pod-based, disposable, and open-system products emerging one after another. How does the FDA plan to adapt to these category changes and improve regulatory predictability?

Brian A. King, Director of the FDA Center for Tobacco Products, answers a question from 2Firsts. Image source | 2Firsts 

Brian A. King said that earlier generations of nicotine products were not effective in helping adults quit smoking. In recent years, many innovative e-cigarette products have emerged, and these products can help adult smokers quit. The FDA is very supportive of this kind of innovation and will work to adapt to these changes and help innovative e-cigarette products enter the U.S. market.